First Time Loading...

Opthea Ltd
ASX:OPT

Watchlist Manager
Opthea Ltd Logo
Opthea Ltd
ASX:OPT
Watchlist
Price: 0.62 AUD Market Closed
Updated: May 2, 2024

Opthea Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Opthea Ltd
Operating Income Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Opthea Ltd
ASX:OPT
Operating Income
-$165.2m
CAGR 3-Years
-66%
CAGR 5-Years
-36%
CAGR 10-Years
-38%
Immutep Ltd
ASX:IMM
Operating Income
-AU$46.9m
CAGR 3-Years
-29%
CAGR 5-Years
-24%
CAGR 10-Years
-13%
Mesoblast Ltd
ASX:MSB
Operating Income
-$55.3m
CAGR 3-Years
21%
CAGR 5-Years
9%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Operating Income
$3.7B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
9%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Operating Income
AU$50.8m
CAGR 3-Years
36%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Operating Income
AU$17.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Opthea Ltd's Operating Income?
Operating Income
-165.2m USD

Based on the financial report for Dec 31, 2023, Opthea Ltd's Operating Income amounts to -165.2m USD.

What is Opthea Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-38%

Over the last year, the Operating Income growth was 6%. The average annual Operating Income growth rates for Opthea Ltd have been -66% over the past three years , -36% over the past five years , and -38% over the past ten years .